Hepatitis B & C

A Personalized Approach to Managing Chronic Viral Hepatitis

Hepatitis B and hepatitis C are both blood-borne viral infections capable of causing long-term, often silent, damage to the liver over many years. Unlike hepatitis A and E, both can become chronic, and both are frequently diagnosed not because a patient feels unwell, but through routine blood testing or screening often after the infection has already been present for some time.

The treatment landscape for these two conditions differs substantially. Hepatitis C is now curable in the vast majority of patients with a course of direct-acting antiviral medication, typically lasting just a few months. Hepatitis B, while not currently curable in the same way, can be very effectively suppressed with long-term antiviral therapy, significantly reducing the risk of progression to cirrhosis or liver cancer. In both cases, the earlier the diagnosis, the better the long-term outcome.

At the practice of Dr. Ashok Choudhury, chronic hepatitis B and C are managed with a clear treatment plan matched to the specific virus, careful staging of any existing liver damage, and structured long-term monitoring where needed.

Hepatitis C Is Curable, and Hepatitis B Is Highly Manageable

Understanding what’s achievable makes the path forward clear

A diagnosis of chronic hepatitis B or C is not a reason for alarm both conditions have effective, well-established treatment pathways, and outcomes for treated patients are generally very good.

The next step is to understand:

  • Which virus you have, and how active the infection currently is
  • How much, if any, liver damage has occurred
  • What treatment options are available for your specific situation
  • What treatment actually involves, and how long it takes
  • Who else might need to be tested, given how these viruses are transmitted
  • What ongoing monitoring is needed, both during and after treatment

The goal is to either cure the infection, in the case of hepatitis C, or achieve durable, effective control, in the case of hepatitis B protecting the liver from long-term damage either way.

Our Approach to Hepatitis B & C

1. Confirm Diagnosis and Assess Disease Activity

Understanding exactly what’s happening with the virus and the liver shapes the entire treatment plan.

  • Confirming infection and viral activity Blood testing confirms diagnosis and measures how actively the virus is replicating, which directly influences treatment decisions.
  • Assessing liver damage Non-invasive tests, and biopsy where needed, assess how much fibrosis or scarring has developed as a result of chronic infection.
  • Screening for co-infections and related conditions Testing for other blood-borne infections and relevant liver conditions is included as part of a thorough initial assessment.
  • Reviewing transmission and family risk Understanding likely transmission route helps identify others, including close contacts and family members, who may need testing.

2. Treat Hepatitis C to Cure

Modern antiviral treatment for hepatitis C is highly effective and well tolerated.

  • Direct-acting antiviral therapy A course of oral antiviral medication, typically lasting a matter of weeks to a few months, cures the infection in the large majority of patients.
  • Selecting the right regimen Treatment regimen and duration are selected based on viral genotype, prior treatment history, and existing liver damage.
  • Confirming cure Blood testing after treatment confirms that the virus has been successfully cleared.
  • Monitoring after cure For patients with more advanced liver damage prior to treatment, ongoing monitoring continues even after cure is confirmed, given residual risk.

3. Suppress and Manage Hepatitis B Long-Term

Hepatitis B treatment focuses on effective long-term viral suppression and liver protection.

  • Assessing the need for treatment Not every patient with hepatitis B requires immediate antiviral treatment; this is determined based on viral activity, liver damage, and other individual factors.
  • Long-term antiviral therapy For patients who need treatment, effective, well-tolerated antiviral medications suppress viral activity and protect the liver over the long term.
  • Monitoring untreated patients Patients not yet needing treatment are monitored on a structured schedule, since the need for treatment can change over time.
  • Special considerations Pregnancy, immunosuppression, and family screening are all specifically considered, given their particular relevance to hepatitis B management.

4. Provide Long-Term Monitoring and Cancer Screening

Because both viruses can affect long-term liver health, structured ongoing monitoring is an important part of care.

  • Regular liver assessment Scheduled blood tests and imaging track liver health over time, both during treatment and in long-term follow-up.
  • Liver cancer screening For patients with significant fibrosis or cirrhosis, regular screening for hepatocellular carcinoma is a core part of ongoing care.
  • Monitoring for cirrhosis-related complications Where advanced liver disease is present, screening for complications such as varices is incorporated into the follow-up plan.
  • Family and contact screening Guidance is given on testing close contacts and family members, given the transmission routes relevant to both viruses.

Why Timely Diagnosis and Treatment Matter So Much

Chronic hepatitis B and C often progress silently for years, causing no symptoms until liver damage is already significant. Given how effective modern treatment now is, particularly the genuine possibility of cure with hepatitis C, timely diagnosis is often the single biggest factor separating a straightforward recovery from years of unnecessary, preventable liver damage.

A Personalized Plan, Not a One-Size-Fits-All Answer

Which virus you have, how active it is, and the treatment approach that’s right for you are all individual. At the practice of Dr. Ashok Choudhury, your treatment plan is built specifically around your diagnosis and stage of disease.

If you have been diagnosed with hepatitis B or C, or think you may be at risk and haven’t yet been tested, a consultation is the right place to start.

Disclaimer

This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a qualified healthcare provider regarding your specific condition.